Literature DB >> 2994800

Sulpiride and the potentiation of progestogen only contraception.

M R Payne, P W Howie, A S McNeilly, W Cooper, M Marnie, L Kidd.   

Abstract

A progestogen (norethisterone) and a dopamine antagonist (sulpiride) were given alone and in combination to volunteers to examine their effects on excretion of ovarian steroids. Compared with non-treatment cycles (n = 15), contraception with a progestogen alone (n = 10) was associated with increased excretion of oestrone and partial suppression of excretion of pregnanediol, suggesting partial luteinization of unruptured follicles. By contrast, the combination of norethisterone and sulpiride (n = 9) suppressed both ovarian steroids to basal values, the suppression being even greater than with sulpiride alone (n = 5). These results suggest that a combination of a progestogen with a dopamine antagonist might have a role in contraception.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2994800      PMCID: PMC1418199          DOI: 10.1136/bmj.291.6495.559

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  13 in total

1.  [One thousand months of contraception with sulpiride].

Authors:  J Buvat; C Decroix-Blacker; F Legal; J P Gasnault
Journal:  Rev Fr Gynecol Obstet       Date:  1976-01

Review 2.  The progestogen-only mini-pill.

Authors:  S Graham; I S Fraser
Journal:  Contraception       Date:  1982-10       Impact factor: 3.375

3.  Effect of breast-feeding patterns on human birth intervals.

Authors:  P W Howie; A S McNeilly
Journal:  J Reprod Fertil       Date:  1982-07

4.  [Variation of serum gonadotropins and progesterone during hyperprolactinemia induced by sulpiride (Dogmatil) during the luteal phasis of the menstrual cycle].

Authors:  P Delvoye; H D Taubert; O Jurgensen; M L'Hermite; J Delogne; C Robyn
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1974-10-21

5.  Hormonal effects of the 300 microgram norethisterone (NET) minipill. I. Daily steroid levels in 43 subjects during a pretreatment cycle and during the second month of NET administration.

Authors:  B M Landgren; E Diczfalusy
Journal:  Contraception       Date:  1980-01       Impact factor: 3.375

6.  Urinary excretion of estrone glucosiduronate, 17 beta-estradiol-17-glucosiduronate, and estriol-16 alpha-glucosiduronate. Significance of proportionate differences during the menstrual cycle.

Authors:  K Wright; D C Collins; J R Preedy
Journal:  Steroids       Date:  1979-10       Impact factor: 2.668

7.  Augmentation of puerperal lactation by oral administration of sulpiride.

Authors:  T Aono; T Shioji; T Aki; K Hirota; A Nomura; K Kurachi
Journal:  J Clin Endocrinol Metab       Date:  1979-03       Impact factor: 5.958

8.  Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use.

Authors:  M C Pike; B E Henderson; M D Krailo; A Duke; S Roy
Journal:  Lancet       Date:  1983-10-22       Impact factor: 79.321

9.  The direct radioimmunoassay of oestrogen glucuronides in human female urine.

Authors:  T S Baker; K M Jennison; A E Kellie
Journal:  Biochem J       Date:  1979-02-01       Impact factor: 3.857

10.  The concentrations of urinary oestrone-3-glucuronide, LH and pregnanediol-3alpha-glucuronide as indices of ovarian function.

Authors:  W P Collins; P O Collins; M J Kilpatrick; P A Manning; J M Pike; J P Tyler
Journal:  Acta Endocrinol (Copenh)       Date:  1979-02
View more
  2 in total

1.  Prolactin response to low dose sulpiride.

Authors:  M E McMurdo; P W Howie; M Lewis; M Marnie; J McEwen; A S McNeilly
Journal:  Br J Clin Pharmacol       Date:  1987-08       Impact factor: 4.335

2.  Sulpiride-induced hyperprolactinemia in mature female rats: evidence for alterations in the reproductive system, pituitary and ovarian hormones.

Authors:  Sara Mostafapour; Samad Zare; Rajab Ali Sadrkhanlou; Abbas Ahmadi; Mazdak Razi
Journal:  Int J Fertil Steril       Date:  2014-07-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.